Detalhe da pesquisa
1.
PRE1BRAZIL Protocol: A Randomized Controlled Trial to Evaluate the Effectiveness and Safety of the DPP-4 Inhibitor Alogliptin in Delaying the Progression of Stage 2 Type 1 Diabetes.
Diabetes Metab Syndr Obes
; 17: 857-864, 2024.
Artigo
Inglês
| MEDLINE | ID: mdl-38406268